Sort   by:  
 Page size 
ProteomicsEpigenetic Silencing by SETDB1 Suppresses Tumor-cell Intrinsic Immunogenicity
Griffin GK, Wu J, Iracheta-Vellve A, Patti JC, Hsu J, Davis T, Dele-Oni D, Du PP, Halawi A, Ishizuka JJ, Kim S, Klaeger S, Knudsen NH, Miller BC, Nguyen T, Olander K, Papanastasiou M, Rachimi S, Robitschek EJ, Schneider EM, Yeary M, Zimmer M, Jaffe JD, Carr SA, Doench JG, Haining WN, Yates KB, Mangu...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2020-12-11 | MSV000086580 | MassIVE
UnknownRacial And Ethnic Disparities In Care Following The New York State Sepsis Initiative.
Not available
S-EPMC6814952 | biostudies-literature
GenomicsDetermining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)

CHD is the leading cause of death in the United States. One of the most common ways to prevent CHD is to take an anti-platelet agent, which lessens platelet aggregation. Two of the most common anti-platelet agents are aspirin and clopidogrel. However, up to 25% to 30% of people do not r...

phs000391.v1.p1 | EGA
UnknownFANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Not available
S-EPMC4550823 | biostudies-literature
UnknownDetermining crystal structures through crowdsourcing and coursework.
Not available
S-EPMC5028414 | biostudies-literature
UnknownInheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Not available
S-EPMC5106833 | biostudies-literature
UnknownNo evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Not available
S-EPMC4938802 | biostudies-literature
UnknownAssessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Not available
S-EPMC4382299 | biostudies-literature
Sort   by:  
 Page size